BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25378411)

  • 1. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
    Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
    Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
    Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis.
    Li R; Luo M; Ren M; Chen N; Xia J; Deng X; Zeng M; Yan K; Luo T; Wu J
    J Vasc Res; 2014; 51(2):110-7. PubMed ID: 24603119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
    Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
    Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
    Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
    Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
    Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
    Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
    FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
    Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
    J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation.
    Most P; Lerchenmüller C; Rengo G; Mahlmann A; Ritterhoff J; Rohde D; Goodman C; Busch CJ; Laube F; Heissenberg J; Pleger ST; Weiss N; Katus HA; Koch WJ; Peppel K
    Circ Res; 2013 Jan; 112(1):66-78. PubMed ID: 23048072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding.
    López-Alemany R; Redondo JM; Nagamine Y; Muñoz-Cánoves P
    Eur J Biochem; 2003 Mar; 270(5):814-21. PubMed ID: 12603314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin.
    Baggott RR; Alfranca A; López-Maderuelo D; Mohamed TM; Escolano A; Oller J; Ornes BC; Kurusamy S; Rowther FB; Brown JE; Oceandy D; Cartwright EJ; Wang W; Gómez-del Arco P; Martínez-Martínez S; Neyses L; Redondo JM; Armesilla AL
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2310-20. PubMed ID: 25147342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia.
    Imoukhuede PI; Dokun AO; Annex BH; Popel AS
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1085-93. PubMed ID: 23376830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.
    Alexander RA; Prager GW; Mihaly-Bison J; Uhrin P; Sunzenauer S; Binder BR; Schütz GJ; Freissmuth M; Breuss JM
    Cardiovasc Res; 2012 Apr; 94(1):125-35. PubMed ID: 22287577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contributions of integrin affinity and integrin-cytoskeletal engagement in endothelial and smooth muscle cell adhesion to vitronectin.
    Stefansson S; Su EJ; Ishigami S; Cale JM; Gao Y; Gorlatova N; Lawrence DA
    J Biol Chem; 2007 May; 282(21):15679-89. PubMed ID: 17403662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside diphosphate kinase B regulates angiogenesis through modulation of vascular endothelial growth factor receptor type 2 and endothelial adherens junction proteins.
    Feng Y; Gross S; Wolf NM; Butenschön VM; Qiu Y; Devraj K; Liebner S; Kroll J; Skolnik EY; Hammes HP; Wieland T
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2292-300. PubMed ID: 25147336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.
    Prager GW; Breuss JM; Steurer S; Olcaydu D; Mihaly J; Brunner PM; Stockinger H; Binder BR
    Circ Res; 2004 Jun; 94(12):1562-70. PubMed ID: 15131009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired cross-activation of β3 integrin and VEGFR-2 on endothelial progenitor cells with aging decreases angiogenesis in response to hypoxia.
    Di Q; Cheng Z; Kim W; Liu Z; Song H; Li X; Nan Y; Wang C; Cheng X
    Int J Cardiol; 2013 Oct; 168(3):2167-76. PubMed ID: 23452889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165.
    Traub S; Morgner J; Martino MM; Höning S; Swartz MA; Wickström SA; Hubbell JA; Eming SA
    Biomaterials; 2013 Aug; 34(24):5958-68. PubMed ID: 23683723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.